Kwality Pharmaceuticals Ltd — Updates, 07-05-2025: Company Update

Kwality Pharmaceuticals has announced a board meeting on May 10, 2025, to review the financial results for the quarter and half-year. The company has successfully completed a regulatory audit in Zimbabwe for its General, Beta-Lactam, Cephalosporin, and Oncology units without any critical observations, reinforcing its focus on quality and compliance. This audit success enhances Kwality’s presence in the ZAZIBONA region, supporting future growth and strategic partnerships across Southern Africa.